Anatara Lifesciences prepares for GaRP-IBS trial results as anti-obesity research gains momentum

Anatara Lifesciences Ltd has announced that its Phase II GaRP-IBS trial is nearing completion, with the final headline analysis scheduled for March 2025. The company, ... Read More